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Poorly differentiated spindle cell neoplasms pose
a diagnostic challenge for dermatopathologists
because of a lack of specific morphologic features
on standard histopathology. Further characterization
with immunohistochemical (IHC) studies is fre-
quently required. We present a fatal case of spindle
cell squamous cell carcinoma (SCC) misdiagnosed as
atypical fibroxanthoma (AFX) based on a limited
panel of IHC markers.
CASE REPORT
A 68-year-old white woman with a history of lung
transplantation presented for evaluation of a 0.9 cm
nodule on the right supraclavicular aspect of the
chest. Shave biopsy results demonstrated a dense
spindle cell proliferation on hematoxylin-eosin
staining (Fig 1). IHC stains were negative for S100
and pan-cytokeratin (AE1/AE3) but positive for
procollagen, leading to a final diagnosis of AFX
(Fig 2). Surgical excision was delayed for 2 months
because of an intervening hospitalization. When
the patient presented for Mohs surgery (MMS), the
lesion was 3.5 cm in diameter (Fig 3). Mohs frozen
sections confirmed an extensive atypical spindle cell
proliferation. Clear margins could not be obtained
after 4 stages of MMS, and concern was raised for
in-transit metastases, as the Mohs mapping showed
noncontiguous tumor spread. Clinically, numerous
subtle 1- to 2-mm subcutaneous papules were then
noted on the chest immediately inferior to the
excision site and extending up to 20 cm away.
Surgery was suspended, and multiple biopsies of
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u.bulk of the tumor were submitted for permanent
histology. All samples were consistent with poorly
differentiated SCC, spindle cell variant, based on
more extensive IHC evaluation (p631, cytokeratin
5/61, 34betaE121, procollagen1, AE1/AE3; Fig 4).
The patient was treated with radiation therapy, but
unfortunately died of her disease within 6 months.DISCUSSION
Spindle cell SCC is an uncommon variant of
cutaneous SCC that typically arises on sun-damaged
skin of elderly adults.1 Solid organ transplant
recipients appear to be at higher risk for this SCC
subtype, whichmay behave aggressively and portend
a poorer prognosis.2 Histopathologic examination
alone is frequently inadequate for diagnosing spindle
cell SCC, as the pleomorphic spindle cells lack
recognizable features of keratinization.3 Distinction
from other spindle cell tumors, mainly AFX and
spindle cell melanoma, necessitates IHC studies.
Furthermore, certain IHC markers for epithelial cells,
especially the commonly used AE1/AE3 pan-
cytokeratin IHC stain, may be negative in spindle cell
SCC and other poorly differentiated SCCs.3 Despite
staining for multiple high and low molecular weightJAAD Case Reports 2015;1:392-4.
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Fig 1. Invasive spindle cell proliferationwithhematoxylin-
eosin stain. (Original magnification: 310.)
Fig 2. Negative IHC staining with pan-cytokeratin (AE1/
AE3). (Original magnification: 320.)
Fig 3. Clinical photograph of the tumor at the time of
MMS. Note the small, skin-colored papules on the chest
wall inferior to the tumor.
Fig 4. Positive IHC staining for HMWK (34betaE12).
(Original magnification: 320.)
JAAD CASE REPORTS
VOLUME 1, NUMBER 6
Benoit, Wisell, and Brown 393keratins, AE1/AE3 pan-cytokeratin stains may still be
negative in some epithelial tumors.
Several case series support the use of high
molecular weight keratins (HMWK) as more sensitive
markers for spindle cell SCC than pan-cytokeratin
alone. Morgan et al4 found 100% sensitivity and
specificity of 34betaE12 for spindle cell SCC, whereas
Sigel et al3 found 69% sensitivity of CK5/6. In addition
toHMWKstains, p63has been identified as reasonably
sensitive and specific for spindle cell SCC, with
sensitivity of 68% to 100% and specificity ranging
from 80% to 100% in distinguishing spindle cell SCC
from AFX.1,5 Other IHC stains that have been useful in
thediagnosis of cutaneous spindle cell SCC arep40, an
isoformof p63, andMNF116, a low- and intermediate-
weight cytokeratin stain.6,7 In the case of our patient,
the correct diagnosis was made based on labeling for
markers specific for HMWK (CK5/6, 34betaE12) and
p63, despite the absence of staining for AE1/AE3
pan-cytokeratin. Clinicians should be careful not
to rely too heavily on a pan-cytokeratin stain
when evaluating spindle cell neoplasms, and should
consider the use of a more robust panel of epithelial
markers.
Spindle cell SCC misdiagnosed as AFX may lead
to delayed therapy and increased morbidity andmortality, especially in the immunocompromisedorgan
transplant population. Clinicians should be aware that
the AE1/AE3 pan-cytokeratin stain may frequently be
negative in spindle cell SCC,while procollagen staining
is often positive. As a result, the diagnosis of AFX, a
much lower risk tumor, may be made rather than the
correct diagnosis of spindle cell SCC. The routine
addition of some combination of epithelial stains,
such as p63, p40, MNF116, and HMWK stains
(34betaE12 or cytokeratin 5/6) in addition to pan-
cytokeratin, S100, and procollagen, to the panel of
IHC markers may improve diagnostic confidence and
patient outcomes when faced with difficult histologic
analysis of cutaneous spindle cell proliferations.
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